Market Tracker

03/29 4:48pm ET

Medicines Co (NASDAQ:MDCO)

50.03
Delayed Data
As of Mar 29
 -0.99 / -1.94%
Today’s Change
29.48
Today|||52-Week Range
55.28
+47.41%
Year-to-Date
Alnylam's LDL-Lowering Drug Positive in Phase II Study
Mar 20 / Zacks.com - Paid Partner Content
Trump, Biogen and Amgen Hammer Healthcare ETFs
Mar 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close51.02
Today’s open50.82
Day’s range49.93 - 51.66
Volume953,985
Average volume (3 months)1,600,365
Market cap$3.6B
Dividend yield--
Data as of 3:59pm ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)+67.46%
Earnings growth (this year)-203.92%
Earnings growth (next 5 years)+72.90%
Revenue growth (last year)-45.69%
P/E ratioNM
Price/Sales14.14
Price/Book5.55

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...+0.50+4.68%
CTLTCatalent Inc+0.10+0.35%
PTHNPatheon NV+0.01+0.04%
GLPGGalapagos NV+1.23+1.45%
Data as of 4:02pm ET, 03/29/2017

Financials

Next reporting dateApril 26, 2017
EPS forecast (this quarter)-$1.29
Annual revenue (last year)$167.8M
Annual profit (last year)-$120.1M
Net profit margin-71.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Clive A. Meanwell
President &
Chief Operating Officer
Tony Kingsley
Corporate headquarters
Parsippany, New Jersey

Forecasts